The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Trends in psychotropic medication use among U.S. adults
Abstract
Purpose: To examine trends and prevalence of prescription psychotropic medication use among noninstitutionalized US adults. Methods: Prescription medication data from the third National Health and Nutrition Examination Survey (NHANES; 1988–1994; n = 20 050) and the 1999–2002 NHANES (n = 12 060), two nationally representative cross‐sectional health examination surveys, were examined for persons aged ≥17 years. Results: The age‐adjusted prevalence of psychotropic medication use increased from 6.1% in 1988–1994 to 11.1% in 1999–2002 (p < 0.001). This was due to more than a three‐fold increase in antidepressant use (2.5%, 1988–1994 vs. 8.1%, 1999–2002 (p < 0.001)). Significant increases between time periods for antidepressant use were seen for all age, gender, and race‐ethnic groups although increases were less pronounced for males than females and non‐Hispanic blacks and Mexican Americans than non‐Hispanic whites. Prevalence of use remained relatively constant from 1988–1994 to 1999–2002 for anxiolytic/sedative/hypnotic (ASH) medications (3.5–3.8%), antipsychotics (0.8–1.0%), and antimanic agents (0.3–0.4%). The age‐adjusted prevalence of multiple psychotropic medication use increased from 1.2% in 1988–1994 to 3.1% in 1999–2002 (p < 0.001). Conclusions: Psychotropic medication use among US adults increased since 1988–1994, specifically of antidepressants. Increases varied by gender and race‐ethnicity indicating under‐utilization for non‐Hispanic blacks and Mexican Americans compared to non‐Hispanic whites for both males and females. Published in 2007 by John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cooper, L. A., Gonzales, J. J., Gallo, J. J., Rost, K. M., Meredith, L. S., Rubenstein, L. V., Wang, N.-Y., & Ford, D. E. (2003) · Medical Care · doi:10.1097/01.mlr.0000053228.58042.e4 · Cited by 651
Disparities in care for depression among primary care patients
Miranda, J., & Cooper, L. A. (2004) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2004.30272.x · Cited by 317
National patterns of medication treatment for depression, 1987 to 2001
Stafford, R. S., MacDonald, E. A., & Finkelstein, S. N. (2001) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v03n0611 · Cited by 94
Cited by
National Patterns in Antidepressant Medication Treatment
Olfson, M., & Marcus, S. C. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.81 · Cited by 730
Ten Putative Contributors to the Obesity Epidemic
McAllister, E. J., Dhurandhar, N. V., Keith, S. W., Aronne, L. J., Barger, J., Baskin, M., Benca, R. M., Biggio, J., Boggiano, M. M., Eisenmann, J. C., et al. (2009) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390903372599 · Cited by 710
Benzodiazepine use and risk of Alzheimer's disease: case-control study
Billioti de Gage, S., Moride, Y., Ducruet, T., Kurth, T., Verdoux, H., Tournier, M., Pariente, A., & Begaud, B. (2014) · BMJ · doi:10.1136/bmj.g5205 · Cited by 558
Benzodiazepine use and risk of dementia: prospective population based study
Billioti de Gage, S., Begaud, B., Bazin, F., Verdoux, H., Dartigues, J.-F., Peres, K., Kurth, T., & Pariente, A. (2012) · BMJ · doi:10.1136/bmj.e6231 · Cited by 436
National Use of Prescription Medications for Insomnia: NHANES 1999-2010
Bertisch, S. M., Herzig, S. J., Winkelman, J. W., & Buettner, C. (2014) · Sleep · doi:10.5665/sleep.3410 · Cited by 305
Metadata
- Authors
- Paulose‐Ram, R., Safran, M. A., Jonas, B. S., Gu, Q., & Orwig, D.
- Venue
- Pharmacoepidemiology and Drug Safety
- Publisher
- Wiley
- Published
- 2007-02-08
- Volume
- 16
- Issue
- 5
- Pages
- 560-570
- ISSN
- 1053-8569 (ISSN-L)
- 1099-1557
- OpenAlex
- W2094233855
- Cited by
- 215
- References
- 3
- FWCI
- 16.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.